statistiche ricercatore

FASANO, MAURO

Distribuzione geografica

Continente	#
NA - Nord America	19.496
EU - Europa	9.782
AS - Asia	5.744
SA - Sud America	532
AF - Africa	126
Continente sconosciuto - Info sul continente non disponibili	19
OC - Oceania	11
Totale	35.710

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	19.287
IT - Italia	4.522
SG - Singapore	1.944
UA - Ucraina	1.481
CN - Cina	1.176
DE - Germania	849
VN - Vietnam	842
SE - Svezia	766
TR - Turchia	716
HK - Hong Kong	651
FI - Finlandia	487
GB - Regno Unito	449
BR - Brasile	434
IE - Irlanda	390
FR - Francia	298
RU - Federazione Russa	222
IN - India	113
CA - Canada	92
MX - Messico	91
JP - Giappone	69
BD - Bangladesh	68
NG - Nigeria	51
BE - Belgio	49
PL - Polonia	44
ES - Italia	43
NL - Olanda	42
CZ - Repubblica Ceca	39
ZA - Sudafrica	35
AR - Argentina	32
KR - Corea	19
EU - Europa	18
PK - Pakistan	18
IQ - Iraq	17
AT - Austria	16
PE - Perù	15
CH - Svizzera	10
CO - Colombia	10
ID - Indonesia	10
LT - Lituania	10
SA - Arabia Saudita	10
VE - Venezuela	10
CL - Cile	9
EC - Ecuador	9
NP - Nepal	9
PH - Filippine	9
EG - Egitto	8
IL - Israele	8
RO - Romania	8
UZ - Uzbekistan	8
AU - Australia	7
DK - Danimarca	7
MD - Moldavia	7
PT - Portogallo	7
PY - Paraguay	7
AE - Emirati Arabi Uniti	6
BG - Bulgaria	6
ET - Etiopia	6
HU - Ungheria	6
JO - Giordania	6
MA - Marocco	6
MY - Malesia	6
TN - Tunisia	6
DZ - Algeria	5
HR - Croazia	5
IR - Iran	5
JM - Giamaica	5
OM - Oman	5
CR - Costa Rica	4
EE - Estonia	4
GR - Grecia	4
KZ - Kazakistan	4
NI - Nicaragua	4
NZ - Nuova Zelanda	4
TH - Thailandia	4
BO - Bolivia	3
KE - Kenya	3
LB - Libano	3
SI - Slovenia	3
SV - El Salvador	3
UY - Uruguay	3
AM - Armenia	2
AZ - Azerbaigian	2
BH - Bahrain	2
DO - Repubblica Dominicana	2
HN - Honduras	2
MM - Myanmar	2
NO - Norvegia	2
QA - Qatar	2
RS - Serbia	2
SY - Repubblica araba siriana	2
TT - Trinidad e Tobago	2
TW - Taiwan	2
AL - Albania	1
BS - Bahamas	1
CG - Congo	1
CI - Costa d'Avorio	1
GE - Georgia	1
GH - Ghana	1
GT - Guatemala	1
HT - Haiti	1
Totale	35.699

Salva come PNG Salva come JPEG

Città	#
Milan	2.925
Fairfield	2.486
Ashburn	1.567
Woodbridge	1.474
Chandler	1.265
San Jose	1.179
Jacksonville	1.141
Singapore	1.105
Seattle	1.020
Houston	1.006
Cambridge	887
Wilmington	857
Hong Kong	646
Ann Arbor	624
Dearborn	459
Princeton	406
Dublin	379
Dallas	377
Beijing	335
Nyköping	335
Izmir	329
The Dalles	317
Chicago	313
Boardman	277
Rome	252
Dong Ket	240
Como	230
Council Bluffs	196
Lauterbourg	182
Munich	180
San Mateo	149
Los Angeles	147
New York	136
Ho Chi Minh City	112
San Diego	111
Helsinki	104
Hanoi	97
Santa Clara	84
Ogden	80
London	76
Orem	67
Tokyo	62
São Paulo	58
Guangzhou	55
Hefei	52
Mexico City	52
Abuja	51
Brussels	49
Varese	44
Denver	43
Montreal	40
Warsaw	40
Buffalo	39
Chennai	36
Kunming	36
Salt Lake City	35
Turku	35
Washington	35
Verona	34
Stockholm	33
Atlanta	32
Nanjing	32
Brooklyn	30
Phoenix	30
Poplar	30
Falls Church	29
Paris	28
Düsseldorf	27
Nanchang	27
Johannesburg	25
Amsterdam	23
Frankfurt am Main	22
Olomouc	22
Shanghai	22
Norwalk	21
Ponte Lambro	21
San Francisco	21
Curitiba	20
Elk Grove Village	20
Jinan	20
Boston	19
Manchester	19
Berlin	18
Brno	17
Redmond	17
Edinburgh	16
Tianjin	16
Cavaria con Premezzo	15
Shenyang	15
Shenzhen	15
Tampa	15
Columbus	14
Hangzhou	14
Da Nang	13
Haiphong	12
Mumbai	12
Naples	12
Nuremberg	12
Philadelphia	12
Pune	12
Totale	25.778

Salva come PNG Salva come JPEG

Nome	#
Experimental setup for the identification of mitochondrial protease substrates by shotgun and top-down proteomics	406
Changes in the two-dimensional electrophoresis pattern of the Parkinson's disease related protein DJ-1 in human SH-SY5Y neuroblastoma cells after dopamine treatment	375
Dopamine induces mitochondrial depolarization without activating PINK1-mediated mitophagy	289
Adolescent THC exposure in female rats leads to cognitive deficits through a mechanism involving chromatin modifications in the prefrontal cortex	282
A meta-analysis of two-dimensional electrophoresis pattern of the Parkinson's disease-related protein DJ-1	276
Flavonoid binding to human serum albumin.	263
Mitochondrial Proteins in the Development of Parkinson’s Disease	259
Ibuprofen binding to secondary sites allosterically modulates the spectroscopic and catalytic properties of human serum heme-albumin	250
Human serum albumin: from bench to bedside.	250
Systems biology analysis of the proteomic alterations induced by MPP+, a parkinson's disease-related mitochondrial toxin	250
Cellular models to investigate biochemical pathways in Parkinson's disease	248
The Depressive Phenotype Induced in Adult Female Rats by Adolescent Exposure to THC is Associated with Cognitive Impairment and Altered Neuroplasticity in the Prefrontal Cortex	247
Evidence for pH-dependent multiple conformers in iron(II) heme-human serum albumin: spectroscopic and kinetic investigation of carbon monoxide binding.	242
Binding of Δ9-tetrahydrocannabinol and diazepam to human serum albumin	237
Multiple isoforms and differential allelic expression of CHRNA5 in lung tissue and lung adenocarcinoma	237
Drugs modulate allosterically heme-fe-recognition by human serum albumin and heme-fe-mediated reactivity	233
Binding of anti-Parkinson's disease drugs to human serum albumin is allosterically modulated.	232
Ibuprofen and warfarin modulate allosterically ferrous human serum heme-albumin nitrosylation.	231
Allostery in a monomeric protein: the case of human serum albumin.	229
Isoniazid and rifampicin inhibit allosterically heme binding to albumin and peroxynitrite isomerization by heme-albumin.	228
Proteome analysis of human substantia nigra in Parkinson's disease	226
Sequence analysis of serum albumins reveals the molecular evolution of ligand recognition properties.	223
Verification of a parkinsons disease protein signature in T-lymphocytes by multiple reaction monitoring	223
H-1 NMR relaxometric characterization of bovine lactoferrin	221
All-trans-retinoic acid and retinol binding to the FA1 site of human serum albumin competitively inhibits heme-Fe(III) association	220
Exploring the mitochondrial degradome by the TAILS proteomics approach in a cellular model of Parkinson's disease	220
O2-mediated oxidation of ferrous nitrosylated human serum heme-albumin is limited by nitrogen monoxide dissociation.	219
Towards a functional definition of the mitochondrial human proteome	217
Proteomics as a tool to investigate cell models for dopamine toxicity	216
Lymphocyte proteomics of Parkinson's disease patients reveals cytoskeletal protein dysregulation and oxidative stress	214
Metal complexes as allosteric effectors of human hemoglobin: An NMR study of the interaction of the gadolinium(III) bis(m-boroxyphenylamide)diethylenetriaminepentaacetic acid complex with human oxygenated and deoxygenated hemoglobin	213
Dopaminergic therapies modulate the T-CELL proteome of patients with Parkinson's disease	213
Abacavir and warfarin modulate allosterically kinetics of NO dissociation from ferrous nitrosylated human serum heme-albumin	212
Thermodynamic analysis of hydration in human serum heme-albumin.	211
Allosteric modulation of drug binding to human serum albumin	210
Reductive nitrosylation of ferric human serum heme-albumin.	210
Characterization of the c.190T>C missense mutation in BRCA1 codon 64 (Cys64Arg).	209
Altered dopamine homeostasis differentially affects mitochondrial voltage-dependent anion channels turnover	208
Allosteric and binding properties of Asp1-Glu382 truncated recombinant human serum albumin - an optical and NMR spectroscopic investigation	207
Discovery and verification of panels of T-lymphocyte proteins as biomarkers of Parkinson's disease	207
Systems biology analysis of the proteomic alterations in Parkinson's disease: Common and disease-specific pathways	207
Peripheral biomarkers of Parkinson's disease as early reporters of central neurodegeneration	205
Mitochondrial proteomics investigation of a cellular model of impaired dopamine homeostasis, an early step in Parkinson's disease pathogenesis	205
Ligand binding to the FA3-FA4 cleft inhibits the esterase-like activity of human serum albumin	203
Deinococcus radiodurans' SRA-HNH domain containing protein Shp (Dr1533) is involved in faithful genome inheritance maintenance following DNA damage	203
A systems biology-led insight into the role of the proteome in neurodegenerative diseases	202
Proteomics and renaissance: accounts of the V Italian Proteomics Association Congress, Florence 2010.	201
Proteomic characterization of Jurkat T leukemic cells after dopamine stimulation: A model of circulating dopamine-sensitive cells	201
Mitochondrial alterations in Parkinson's disease human samples and cellular models	201
Demonstration of fibrinogen-FcRn binding at acidic pH by means of Fluorescence Correlation Spectroscopy	201
Heme binding to albuminoid proteins is the result of recent evolution	200
1H NMR RELAXOMETRIC AND OPTICAL ABSORBANCE CHARACTERIZAZION OF THE INTERACTION OF MANGANESE PORPHYRINS WITH HUMAN SERUM ALBUMIN	199
Proteomics in Parkinson's disease: An unbiased approach towards peripheral biomarkers and new therapies	198
Diagnostic Salivary Tests for SARS-CoV-2	198
Allosteric modulation of anti-HIV drug and ferric heme binding to human serum albumin	197
AN NMR-STUDY OF THE INTERACTION BETWEEN MELANIN FREE ACID AND MN2+ IONS AS A MODEL TO MIMIC THE ENHANCED PROTON RELAXATION RATES IN MELANOTIC MELANOMA	196
Ibuprofen modulates allosterically NO dissociation from ferrous nitrosylated human serum heme-albumin by binding to three sites.	196
Molecular phylogenetic analyses of albuminoids reveal the molecular evolution of allosteric properties	196
Method for the in vitro diagnosis of parkinson's disease	195
Q-band EPR investigations of neuromelanin in control and Parkinson's disease patients	192
Cellular response to empty and palladium-conjugated amino-polystyrene nanospheres uptake: A proteomic study	192
Saliva is a reliable tool to detect SARS-CoV-2	191
PARAMAGNETIC GD-III-FE-III HETEROBIMETALLIC COMPLEXES OF DTPA-BIS-SALICYLAMIDE	189
Isolation and C-13-NMR characterization of an insoluble proteinaceous fraction from substantia nigra of patients with Parkinson's disease	189
Is neuromelanin changed in Parkinson's disease? Investigations by magnetic spectroscopies	189
Rapid salivary test suitable for a mass screening program to detect SARS-CoV-2: a diagnostic accuracy study	189
Toward the Standardization of Mitochondrial Proteomics: The Italian Mitochondrial Human Proteome Project Initiative	186
Saggio rapido per la diagnosi in vitro di infezione da SARS-CoV-2 in un fluido biologico	186
Mn(II) binding to human serum albumin: A (1)H-NMR relaxometric study.	185
Abacavir modulates peroxynitrite-mediated oxidation of ferrous nitrosylated human serum heme-albumin	184
Pseudo-enzymatic hydrolysis of 4-nitrophenyl myristate by human serum albumin.	184
SYNTHESIS AND CHARACTERIZATION OF A NOVEL DTPA-LIKE GADOLINIUM(III) COMPLEX - A POTENTIAL REAGENT FOR THE DETERMINATION OF GLYCATED PROTEINS BY WATER PROTON NMR RELAXATION MEASUREMENTS	183
A new ytterbium chelate as contrast agent in chemical shift imaging and temperature sensitive probe for MR spectroscopy	182
Proteomic analysis of dopamine and α-synuclein interplay in a cellular model of Parkinson's disease pathogenesis	182
The five-to-six-coordination transition of ferric human serum heme-albumin is allosterically-modulated by ibuprofen and warfarin: a combined XAS and MD study.	182
Digital and analogical reality in proteomics investigation	181
Parkinson's disease plasma biomarkers: An automated literature analysis followed by experimental validation	181
EVIDENCE FOR A GLYCIDIC-LIPIDIC MATRIX IN HUMAN NEUROMELANIN, POTENTIALLY RESPONSIBLE FOR THE ENHANCED IRON SEQUESTERING ABILITY OF SUBSTANTIA-NIGRA	179
Azide, cyanide, fluoride, imidazole and pyridine binding to ferric and ferrous native horse heart cytochrome c and to its carboxymethylated derivative: A comparative study	179
1H-NMR relaxometric analysis of drug binding effects to global unfolding of human serum albumin.	178
Alpha-synuclein and Parkinson's disease: a proteomic view	178
Integrative proteomics: perspective in complex system interpretation.	178
Stabilization of the T-state of human hemoglobin by proflavine, an antiseptic drug	177
Prevention and modulation of aminoglycoside ototoxicity (Review)	177
Prototropic and water-exchange processes in aqueous solutions of Gd(III) chelates	176
H-1-NMR relaxometric study of pancreatic serine (pro)enzyme inhibition by a Gd(III) chelate bearing boronic functionalities	175
Ibuprofen impairs allosterically peroxynitrite isomerization by ferric human serum heme-albumin.	175
Serum heme-albumin: an allosteric protein.	175
Looking at COVID-19 from a Systems Biology Perspective	175
Warfarin inhibits allosterically the reductive nitrosylation of ferric human serum heme-albumin	174
Neonatal Fc receptor is involved in the protection of fibrinogen after its intake in peripheral blood mononuclear cells	174
The drug-dependent five- to six-coordination transition of the heme-Fe atom modulates allosterically human serum heme-albumin reactivity	174
Metodo per la diagnosi in vitro della malattia di Parkinson	173
Sviluppo di un modello cellulare della disfunzione mitocondriale nella malattia di Parkinson nella linea cellulare SH-SY5Y in seguito a trattamento con dopamina o MPP+ ed analisi proteomica dei profili di espressione proteica dei mitocondri in modelli di patologie neurodegenerative.	172
Heme-based catalytic properties of human serum albumin	170
Proteomica	169
H-1 and O-17-NMR relaxometric investigations of paramagnetic contrast agents for MRI. Clues for higher relaxivities	167
Reversible two-step unfolding of heme-human serum albumin: a H-1-NMR relaxometric and circular dichroism study	166
Biomarkers of Parkinson’s disease	166
NMR-STUDIES OF MELANINS - CHARACTERIZATION OF A SOLUBLE MELANIN FREE ACID FROM SEPIA INK	166
Totale	20.707

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	137.958
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	137.958

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	558	0	0	0	0	0	0	0	0	0	0	0	558
2021/2022	2.362	300	403	166	84	109	77	145	114	113	308	211	332
2022/2023	3.277	311	194	268	345	224	645	10	459	484	118	137	82
2023/2024	4.722	751	762	748	838	931	248	34	148	114	25	20	103
2024/2025	3.381	18	44	587	98	111	187	162	282	366	410	275	841
2025/2026	7.394	449	456	305	974	825	438	1.558	448	946	487	330	178
Totale													35.842